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Crystal structurePeriplasmic adaptor proteins are key components of bacterial tripartite efﬂux pumps. The 2.85 Å
resolution structure of an MFS (major facilitator superfamily) pump adaptor, Aquifex aeolicus EmrA,
shows linearly arranged a-helical coiled-coil, lipoyl, and b-barrel domains, but lacks the fourth
membrane-proximal domain shown in other pumps to interact with the inner membrane trans-
porter. The adaptor a-hairpin, which binds outer membrane TolC, is exceptionally long at 127 Å,
and the b-barrel contains a conserved disordered loop. The structure extends the view of adaptors
as ﬂexible, modular components that mediate diverse pump assembly, and suggests that in MFS tri-
partite pumps a hexamer of adaptors could provide a periplasmic seal.
 2014 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical
Societies. This is an open access article under the CC BY license (http://creativecommons.org/licenses/
by/3.0/).1. Introduction
Tripartite efﬂux pumps expel a wide range of noxious mole-
cules, including antibiotics, metals, detergents and bile salts from
Gram-negative bacteria such as Escherichia coli and Pseudomonas
aeruginosa, and they are major drivers of the increasing threat of
multiple antibiotic resistance [1,2]. Efﬂux substrates bind to an
inner membrane (IM) transporter, e.g. in E. coli an ATPase like
MacB or a proton antiporter like the RND (resistance nodulation
division) AcrB or MFS (major facilitator superfamily) EmrB, and
are delivered to the outer membrane (OM)-anchored TolC exit
duct, the entrance to which projects into the periplasm [1–3]. In
all pumps, an essential third component is the periplasmic adaptor
(e.g. E. coli AcrA or EmrA), shown by extensive in vivo cross-linking
and multidomain docking of the E. coli AcrA-AcrB-TolC RND-
dependent pump to establish and stabilise interactions with
both TolC and AcrB [4–6]. Structural analyses have indicated thatvariation among pumps is underpinned by a ﬂexible, linearly
arranged, multidomain adaptor architecture [5,7–11], in which
three b-sheet domains – lipoyl, b-barrel and membrane proximal
– interact with the 70 Å periplasmic extension of RND IM trans-
porters, while a fourth domain, an a-helical hairpin, establishes
extensive coiled-coil interactions with the periplasmic a-helical
barrel of TolC [1,4,5]. The recent ﬁnding that the a-hairpin is com-
pletely absent from an adaptor of the spirochete Borrelia burgdor-
feri emphasizes that adaptor variation can be substantial in
effecting assembly of different pumps [10].
In the structurally uncharacterised MFS-dependent efﬂux
pumps, such as E. coli EmrAB-TolC [12–16], E. coli EmrKY-TolC
[17], Vibrio cholerae VceAB-VceC [18,19], Neisseria gonorrhoeae
FarAB-MtrE [20] and Stenotrophomonas maltophilia EmrAB-EmrC
[21], component interactions must indeed differ from RND-depen-
dent pumps as their primary sequences, together with structural
characterisation of related autonomous MFS transporters such as
QacA, Sge1, PepTSo and PepTst [12,22–25], indicate that transport-
ers in MFS-dependent tripartite machineries lack the large
periplasmic extension that is important in RND pump assembly.
In many organisms such as Aquifex aeolicus, V. cholerae, S. malto-
philia, P. aeruginosa, Cupriavidus metallidurans and Burkholderia
pseudomallei the tripartite MFS pump is organized in an operon
with genomic structure 50-OM pump-adaptor-MFS transporter-30,
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an operon (E. coli TolC is separate as it is utilized by myriad MFS,
ABC and RND transporters). Component interactions of MFS-
dependent pumps have been evidenced in vitro, EmrA-EmrB inter-
action by electron microscopy [26] and EmrA-TolC using surface
plasmon resonance [27]. The stoichiometry is unknown, though
the adaptor EmrA, which is anchored to the IM by a single trans-
membrane (TM) helix [15], can form dimers and trimers in vitro
[15], and electron microscopy of a reconstituted EmrAB complex
suggested the formation of a ‘dimer-of-dimers’ [26]. The physio-
logical relevance of such oligomers, e.g. how they would interact
with trimeric TolC and enable substrates to bypass the periplasm
through EmrAB-TolC, remains to be seen.
The structure of the closely conserved TolC exit duct has been
known for 14 years [3], but an understanding of EmrAB-TolC
assembly and operation requires structural information for the
IM and periplasmic pump components. Here we present the struc-
ture of MFS adaptor EmrA from A. aeolicus, revealing features that
appear speciﬁc to the MFS efﬂux pumps.
2. Materials and methods
2.1. Expression of soluble Aquifex aeolicus EmrA protein
To produce native, soluble Aquifex aeolicus EmrA (aaEmrA), E.
coli SoluBL21 cells bearing pET24-aaEmrADTM (see Supplemental
data for cloning methods) were grown at 30 C in 2xTY medium
containing 50 lg ml1 kanamycin to A600 0.6, when 0.5 mM IPTG
was added for 16 h at 18 C. Cells harvested by centrifugation were
resuspended in 50 mM Tris pH 7.4, 400 mM NaCl, 5% glycerol, 10%
MgCl2 supplemented with EDTA-free protease inhibitor (Roche).
Cells were broken by two 30000 psi passages through a cell disrup-
tor. After centrifugation at 150000g for 1 h at 4 C, supernatant
was incubated with Proﬁnity IMAC resin (Biorad) and 4 mM imid-
azole for 1 h at 4 C. Resin was washed in buffer A (25 mM HEPES
pH 7.5, 400 mM NaCl, 4 mM imidazole) containing 0.1% Triton X-
100, then in buffer A alone. Protein was eluted in 25 mM HEPES
pH 7.5, 200 mMNaCl and 400 mM imidazole. Imidazole concentra-
tion was reduced to 10 mM using an Amicon 10kDA molecular
weight cut-off concentrator (Millipore). Final protein concentra-
tion was 7 mg ml1. Selenomethionine-incorporated EmrA was
produced using a metabolic inhibition protocol [28]. E. coli
SoluBL21 (DE3) (Genlantis) cells bearing pET24-EmrADTM plasmid
were grown at 37 C to A600 0.5 in M9 minimal media supple-
mented with 50 lg ml1 kanamycin, 0.2% glucose, 2 mM MgSO4,
0.1 mM CaCl2 and 0.001% thiamine. At this point 100 mg L1
threonine, lysine and phenylalanine, 50 mg L1 leucine, isoleucine
and valine and 60 mg L1 selenomethionine were added and cells
grown for a further 45 min. 0.5 mM IPTG was then added for
16 h at 18 C. Protein was puriﬁed as native with the addition of
1 mM TCEP to all buffers. Incorporation of 2 selenomethionine res-
idues was conﬁrmed by mass-spectrometry. The ecEmrA protein
lacking the TM domain was produced from plasmid pET24-
ecEmrADTM and puriﬁed as native aaEmrA.
2.2. Crystallisation, structure determination and analysis
Crystallisation of aaEmrA was conducted using sitting drop
vapour diffusion at 15 C in CrysChem 24 well plates (Hampton
Research). Drops were formed by mixing 2 ll of protein solution
with 2 ll of crystallisation reagent (100 mM MES pH 6.5,
100 mM MgCl2, 10% isopropanol, 8% PEG4000) and equilibrated
against 500 ll. Crystals grew to maximum size (0.8 mm 
0.2 mm  0.2 mm) in seven days, and were cryoprotected by step-
wise addition of cryoprotectant (100 mM MES pH 6.5, 50 mMMgCl2, 5% isopropanol, 10% PEG4000, 42.5% MPD), before being
looped and ﬂash-frozen in liquid nitrogen. Diffraction data were
collected at 100 K on beamline I24 (Diamond Light Source, UK).
X-ray data sets were indexed and integrated using XDS [29] and
scaled using Aimless in the CCP4 suite [30]. Crystallographic
phases for the 3.5 Å selenomethionine dataset were obtained by
the Single-wavelength Anomalous Dispersion (SAD) method, with
two selenium sites identiﬁed using ShelxD [31]. Sites were reﬁned
and an initial 3.5 Å resolution density modiﬁed map created using
Autosharp. Density modiﬁcation was then performed in Resolve
using the isomorphous 2.85 Å high-resolution data, maintaining
the same ‘free’ reﬂection list and using the initial SeMet sites and
electron density map from the SAD data. An initial model of EmrA
was built with AutoBuild in Phenix. The structure was completed
with iterative rounds of manual model-building with Coot [32]
and reﬁnement in Phenix [33]. Structure validation was assisted
by Molprobity [34] and Procheck [35]. The ﬁnal model encom-
passes one molecule of EmrA (residues 27–321 and 343–373), 6
water molecules, 2 isopropanol molecules and a magnesium ion,
with no Ramachandran outliers. The atomic coordinates and struc-
ture factors have been deposited in the Protein Data Bank (http://
www.rcsb.org/), PDB ID: 4TKO. Root mean square deviations
(RMSDs) were calculated over Ca atoms aligned using superpose
in the CCP4 suite [36]. The colour scheme of conserved residues
in Supplemental Fig. 4 was generated with CONSURF [37,38].
Figures were prepared using PyMol [39].
3. Results and discussion
3.1. Crystallisation and structure determination of Aquifex aeolicus
EmrA
Sequence analysis of EmrA proteins (360–423 amino acids in
length, Supplemental Fig. 1) reveals the N-terminus consists of a
short (6–32 amino acid), unconserved cytoplasmic domain preced-
ing a TM helix, analogous to the AcrA lipid attachment, that
anchors the adaptor in the IM. To facilitate structural studies, we
cloned and expressed EmrA from E. coli and 5 homologues, engi-
neered to lack the TM helix (see Supplemental Methods). Most
either failed to crystallise or otherwise produced non-diffracting
crystals, but we were able to solve the structure of Aquifex aeolicus
EmrA (aaEmrA) from a construct encompassing residues 26
onwards of the 374 residue mature sequence. Native aaEmrA crys-
tallised in space group I4122 with a 78% solvent content and one
molecule in the asymmetric unit. Phasing using molecular replace-
ment with adaptor homologues was unsuccessful. Selenomethio-
nine derivatised aaEmrA crystallised as native and phases were
calculated using a 3.5 Å resolution single-wavelength anomalous
diffraction (SAD) dataset (Table 1) and the positions of two
methionine residues and an initial density modiﬁed map were
determined. These were used as starting points to calculate the
electron density map of an isomorphous 2.85 Å resolution dataset
into which an atomic model could be built (Table 1). The ﬁnal
reﬁned model contains residues 27–321 and 343–373 with an
Rwork and Rfree of 20.8 and 24.8, respectively. Residues 26, 322–
342 and 374 could not be built due to poorly deﬁned electron
density.
3.2. EmrA lacks a membrane proximal domain present in adaptors
from distinct pumps
The structure contains three linearly arranged domains, an a-
helical hairpin, a lipoyl domain and a b-barrel domain (coloured
blue, green and yellow in Fig. 1). While this domain organisation
is similar to other structurally characterised adaptors, most
Fig. 1. Overall structure of Aquifex aeolicus EmrA. EmrA is coloured by domain in
yellow (b-barrel), green (lipoyl) and blue (a-helical coiled coil). The b-barrel
contains the N and C-termini (labelled) and anchors EmrA in the inner membrane
(IM) via an N-terminal TM helix (yellow tube). Due to poorly deﬁned density for
residues 322–342, there is a break in the b-barrel with residues 321 and 343 (red
spheres) indicating the beginning and end of modelled residues for this loop.
Table 1
Data collection and reﬁnement statistics.
aaEmrA – SeMet aaEmrA – native
Data collection
Space group I4122 I4122
Cell dimensions
a, b, c (Å) 81.15, 81.15, 540.24 81.37, 81.37, 541.70
a, b, c () 90, 90, 90 90, 90, 90
Wavelength 0.96861 1.03836
Resolution (Å) 39.34–3.46 (3.79–3.46) 29.67–2.85 (3.00–2.85)
Rmerge 0.170 (0.640) 0.171 (0.476)
I/rI 14.8 (4.8) 9.70 (3.30)
Completeness (%) 99.5 (98.0) 99.98 (100.00)
Redundancy 16.6 (16.8) 11.9 (11.3)
Reﬁnement
Resolution (Å) 29.67–2.85
No. reﬂections 22150
Rwork/Rfree 20.8/24.8
No. atoms
Protein 2654
Ligand/ion 9
Water 6
B-factors (Å2)
Protein 71.05
Ligand/ion 64.00
Water 52.2
R.m.s. deviations
Bond lengths (Å) 0.008
Bond angles () 0.99
Ramachandran plot
Outliers (%) 0
Allowed (%) 1.86
Favoured (%) 98.14
Values in parentheses are for highest-resolution shell.
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identiﬁed to date in all 6 RND and ATP-binding cassette (ABC)
adaptor crystal structures [7–11,40]. Therefore, distinctively for
periplasmic adaptors, the b-barrel is proximal to the IM, anchored
via its N-terminal TM helix. Sequence alignment (Supplemental
Fig. 1) of EmrA homologues from 13 diverse bacteria indicates
the lack of an MP domain is not unique to A. aeolicus. Some EmrA
adaptors have non-conserved C-terminal extensions (19 and 41
residues in V. cholerae VceA and ecEmrA, respectively) but these
extra residues are insufﬁcient to form an MP domain, which are
usually 84–108 residues long. In fact, the C-terminal residues of
ecEmrA are predicted to form a short a-helix [15], not the usual
b-roll topology of MP domains. In addition, the N-terminal TM
helix is directly attached to the b-barrel domain in all EmrA
homologues, positioning this domain closest to the membrane
and indicating the extra C-terminal residues do not form a fourth
EmrA domain adjacent to the membrane.
In contrast to EmrA, the membrane attachment site in RND and
ABC adaptors is located at the MP domain (e.g. an N-terminal lipoyl
group in RND AcrA or an N-terminal TM helix in ABC MacA). In
RND-dependent tripartite pumps, the MP domain is known to
make extensive interactions with the periplasmic extension of IM
transporters [5,41]. This MP domain would not be required for
EmrA-EmrB interactions in MFS pumps as there is no such
periplasmic extension of the IM EmrB transporter.
3.3. An exceptionally long a-helical coiled-coil in the MFS adaptor
EmrA
The aaEmrA anti-parallel, two-stranded, a-helical coiled-coil
domain is 168 residues and 127 Å long with 11 heptad repeats
per helix. The N-terminal helix consists of residues 77–160, andthe C-terminal helix residues 165–244 (Fig. 1). The coil is non-ideal
due to positively charged residues in its hydrophobic core, i.e. K84,
K98, R130, R182 and K119 reside in normally hydrophobic A and
D heptad positions. In addition, the heptad repeat pattern is
disrupted by a four residue insertion in the N-terminal helix (res-
idues 112–115) and a three residue insertion in the C-terminal
helix (residues 210–212), approximately 70 Å from the tip of the
structure, and close to the centre of the coiled-coil. This disrupts
the knobs-into-holes packing, resulting in a weakened inter-helical
interaction in this region of the coil. Heptad shifts, also called
‘‘stutters’’ and ‘‘stammers’’, are usually found in a-ﬁbrous proteins
with an extended coiled-coil structure such as myosin and ﬁbrino-
gen, where it is suggested they may serve as points of ﬂexibility for
extremely long coiled-coils [42,43]. The shifts here likely result in
relative ﬂexibility in this region, evident as high Ca B-factors over
the centre of the aaEmrA coiled-coil (an average of 124 Å2 over
residues 102–125 and 200–222 compared to 90 Å2 over the entire
a-hairpin and 71 Å2 over the whole structure, Supplemental
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(21% over coil residues 77–244 compared to 14% over the full
structure) resulting in a positive charge distribution (the electro-
static charge over the aaEmrA surface is presented in Supplemental
Fig. 2B), particularly evident in the centre of the coil (residues 119–
136 and 184–202 contain 31% lysine residues) close to the heptad
phase shifts.
An alignment of structurally characterised adaptors to date
(Supplemental Fig. 3) highlights the differences in the length of
adaptor a-hairpins. The 127 Å long coiled-coil of aaEmrA is at least
twice as long as the a-hairpins of the multidrug RND adaptors AcrA
and MexA (58 Å and 47 Å long, respectively [11,40]), the heavy
metal efﬂux RND adaptor ZneB (52 Å long [7]) and the drug efﬂux
ABC adaptor MacA (67 Å long [9]) (Fig. 2). The length of the aaEmrA
a-hairpin is even more pronounced when compared to the 27 Å
long a-hairpin of the heavy metal efﬂux adaptor CusB, which con-
tains an unusual three-helix bundle [8], and the recently published
structure of BesA, an RND adaptor from the Spirochaete B. burgdor-
feri, which has no a-hairpin at all [10]. CusB therefore remains the
only characterised adaptor that forms a more elaborate three-
stranded coiled-coil instead of the typical two-stranded coils found
in all other adaptors, including EmrA. Primary sequence analysis of
EmrA homologues (Supplemental Fig. 1) suggests the minimum
EmrA a-hairpin length is 118 residues (e.g. ecEmrA), while coils
similar in length to aaEmrA are predicted in pathogenic V. cholerae
VceA (146 residues/115Å long) as well as Thermodesulfobium
narugense (130 residues/95Å long).
Structural alignment of the aaEmrA adaptor a-hairpin with
those fromMexA, ZneB, AcrA, CusB and MacA results in low RMSDs
(1.22–1.70 Å), with the hairpins superposed to the top half of the
aaEmrA a-hairpin (residues 116–206) (Fig. 2). The a-hairpins of
MexA and AcrA are known to bind to the cognate OM exit duct TolCFig. 2. Structural alignment of adaptor a-helical coiled-coils. Left, overlay of Aquifex aeo
(cyan, 2F1M), C.metallidurans ZneB (grey, 3LNN), E. coli CusB (purple, 3OOC) and E. coliM
hairpin to EmrA, calculated using superpose in the CCP4 suite, indicated below the respec
are labelled.[1], suggesting there is close structural topology in the TolC inter-
acting region of adaptors, including EmrA. It is therefore likely the
pseudo three-fold symmetry created by the coiled-coil interactions
of TolC with RND adaptors [4,5] are also key to EmrA-TolC interac-
tions, and suggests EmrA may function similarly to RND adaptors
in stabilising TolC opening [1,5,44].
3.4. Closely conserved b-barrel and lipoyl domains
The lipoyl and b-barrel domains are the only two domains that
are conserved in structurally characterised adaptors from different
pumps and organisms (EmrA lacks an MP domain and Borrelia BesA
lacks an a-hairpin, see Supplemental Fig. 3). The lipoyl domain is
structurally similar in all adaptors including EmrA (RMSDs
1.24 Å, 1.19 Å, 1.70 Å, 1.04 Å, 1.22 Å, 1.29 Å for AcrA, BesA, CusB,
MacA, ZneB and MexA, respectively). Likewise, the EmrA b-barrel
domain (Fig. 3A) shares structural topology with the b-barrel
domains of adaptors BesA, MexA, AcrA, CusB, ZneB and MacA
(RMSDs 1.54 Å, 2.27 Å, 2.04 Å, 2.08 Å, 1.34 Å and 1.33 Å, respec-
tively) (Fig. 3B). However, the aaEmrA b-barrel contains 21 disor-
dered residues, unobserved due to a break in the electron density
(residues 322–342). Modelling of this region indicates it can form
a 23 Å long loop, approximately the same length as the b-barrel
strands (Fig. 3C). In other adaptors the equivalent loop is less than
half the size, typically 7 residues long, highlighted in the b-barrel
superposition in Fig. 3D. Alignment of EmrA proteins from diverse
bacteria reveals a number of highly conserved residues in this long
loop (Fig. 3E), including strictly conserved residues F327, P331,
G337 and K341 (aaEmrA numbering). The loop is one of the most
conserved regions in the EmrA structure and is not seen in any of
the other EmrA b-barrel loops (Supplemental Fig. 4) or in other
adaptors, indicating it may have a functional role in MFS pumps.licus EmrA (blue) with adaptors P. aeruginosa MexA (red, PDB: 2V4D), E. coli AcrA
acA (yellow, 3FPP). Right, adaptors aligned with the RMSDs (in Å) of each adaptor a-
tive structure (number of aligned residues in brackets). N- and C- terminal residues
Fig. 3. Structural alignment of adaptor b-barrels. (A) EmrA b-barrel. Red spheres indicate modelled residues (labelled) at the beginning and end of the disordered region. (B)
Superposition of adaptor b-barrels. EmrA (yellow), MexA (cyan), AcrA (pink), ZneB (blue), CusB (red), BesA (green) and MacA (orange) were aligned using superpose in the
CCP4 suite. RMSDs between b-barrels are tabulated to the right (number of aligned residues in brackets). (C) Disordered loop in EmrA. The disordered residues have been
modelled (grey loop) as a simple loop projecting out from the b-barrel. (D) Superposition of adaptor b-barrels, highlighting the disordered loop region. Coloured as in (B) and
(C). (E) Sequence alignment of EmrA homologues. Alignment was performed over the whole sequence, but for clarity only the region covering the disordered loop is shown.
Sequences are from Aquifex aeolicus (aaEmrA), Escherichia coli (ecEmrA and ecEmrK), Vibrio cholerae (vcVceA), Stenotrophomonas maltophilia (smEmrA), Rhodobacter capsulatus
(rcEmrA), Salmonella Typhimurium (stEmrA), Pseudomonas aeruginosa (paEmrA), Thermodesulfobium narugense (tnEmrA), Cupriavidus metallidurans (cmEmrA), Burkholderia
pseudomallei (bpEmrA), Haemophilus inﬂuenza (hiEmrA), Neisseria gonorrhoeae (ngFarA). Strictly conserved residues are boxed in white on a red background and highly
conserved residues are boxed in red on a white background. Secondary structure is indicated above and coloured by domain as Fig. 1.
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calorimetry or co-crystallisation
The initial observation that adaptor b-barrel topology is also
found in domains involved in ligand binding prompted the idea
adaptors may have a role in substrate engagement [40]. Indeed,
this seems to be the case for the heavy metal efﬂux pump adaptors
ZneB and CusB in which crystal structures have revealed Zn and Cu
ions bound in the ﬂexible linker region between the b-barrel and
membrane proximal domain [7,8]. Substrate binding to ecEmrA
lacking the TM helix was previously inferred from changes in the
degree of iodide-induced quenching of intrinsic protein ﬂuores-
cence upon addition of hydrophobic substrates nalidixic acid, CCCP
or DNP [15]. Here, we used isothermal titration calorimetry (ITC) to
investigate drug binding to constructs of ecEmrA or aaEmrA lack-
ing the TM domain. The titration of 1 mM DNP and 10 mM nali-
dixic acid to 0.1 mM ecEmrA or aaEmrA did not result in a
detectable interaction between substrate and adaptor (Supplemen-
tal Fig. 5). Neither could we observe any difference density consis-
tent with bound substrates in co-crystal trials of 0.5 mM CCCP and
0.5 mM DNP with aaEmrA (data not shown). If EmrA does facilitatedrug transfer through the tripartite pump by binding substrates as
suggested [15], it is not detectable by ITC or crystallography.
3.6. Implications of the EmrA adaptor structure for assembly of the
MFS-dependent pump
Tripartite efﬂux pumps span both inner and outer membranes,
providing a continuous seal for drugs to bypass the periplasm.
Extensive in vivo cross-linking analyses have shown that in
AcrAB-TolC a 170 Å long periplasmic seal can be provided by close
ﬁt of IM and OM components (AcrB and TolC, respectively)
[6,45,46] stabilised by interactions with the adaptor (Fig. 4, left)
[1,4,5]. In EmrAB-TolC, the inner membrane MFS component does
not contain signiﬁcant periplasmic structure, so it follows the seal
would be provided by the adaptor and TolC a-barrel. If six EmrA
molecules are modelled into a ring, formed by lipoyl and b-barrel
interactions, and close side-to-side packing of the lower EmrA a-
hairpin regions (Fig. 4, right) that are equivalent to the upper TolC
a-barrel, small gaps between b-barrel domains can only be sealed
by modelling the disordered 21 b-barrel residues. In addition, the
TolC-interacting regions of the a-hairpins naturally diverge in the
Fig. 4. Putative assembly of the EmrAB-TolC pump. Left, assembled E. coli TolC
(red)-AcrA (green)-AcrB (blue) pump, based on in vivo site-speciﬁc cross-linking
and data-based multidomain docking. Right, putative assembly of Aquifex EmrA
(green)-EmrB (blue, corresponding to an outline of the homologous 14 TM MFS
transporter PepTSo [25])-TolC (red). To form a seal against the periplasm for drugs to
bypass inner and outer membranes (IM and OM, respectively) we have modelled a
ring of six adaptors.
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Only by docking the TolC open form [44] into the EmrA hexamer’s
upper half could we form a sealed periplasmic efﬂux channel, with
a 225 Å periplasmic spanning distance (Fig. 4, right). While this
length is similar to the cryo-electron microscopy model of the
AcrAB-TolC complex formed by non-natural linked fusion proteins
[47], it is longer than the in vivo data driven model of AcrAB-TolC
(170 Å, Fig. 4, left) and the in vitro bipartite MexA-OprM cryo-
tomography model (210Å) [1,5,48]. In our speculative EmrAB-TolC
model the EmrA a-hairpin tips interact with the TolC periplasmic
entrance coils, similar to previous in vivo and in vitro observations
of adaptor-TolC coiled-coil interactions in RND-dependent tripar-
tite machineries [4,5]. EmrA-TolC interactions would be aided by
inter-domain movement around the adaptor’s ﬂexible linker
regions [5,10,11,49], previously identiﬁed as key to tripartite pump
assembly [1,5]. This hexameric ring of adaptors is also observed in
the co-crystal structure of an adaptor-transporter complex (CusB-
CusA [41]) and the in vitro cryo-electron microscopy based model
of an AcrAB-TolC complex formed by linked fusion proteins [47],
suggesting the seal in these systems could also be provided by a
ring of 6 adaptors, stabilised by interactions through the b-barrel
and lipoyl domains. As for adaptor-transporter interactions, the
single TM helices of EmrA would seem likely to form substantial
contacts with the predicted 14 TM helices of EmrB. Indeed, the
putative ring of b-barrels from the six EmrA adaptors would have
an internal diameter similar to the size of monomeric structurally
characterised 14 TM MFS adaptors (oligopeptide transporters
PepTSo [25] and PepTSt [23]), suggesting the single TM helices of
the 6 adaptors could interact with monomeric EmrB by forming
a 20-helix bundle in the IM. While we require further experimental
evidence to support the model, this arrangement would contrast
with the ‘dimer-of-dimers’ suggested by electron microscopy of
puriﬁed EmrA and EmrB [26].Acknowledgements
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